Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bofors Nobel-Pharma
Mölndal, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
AB Bofors Nobel-Pharma was a Swedish pharmaceutical company established in 1967 as a spin-off of the civil chemical division of the defense and industrial group AB Bofors. Based in Mölndal, Sweden, the company was highly successful in research and development, notably developing the widely used local anesthetics mepivacaine (Carbocain) and bupivacaine (Marcain). In the 1970s, Bofors Nobel-Pharma collaborated with Astra AB, which eventually acquired its patent portfolio, including the research project that led to the blockbuster corticosteroid budesonide (Pulmicort). The company's pharmaceutical operations were wound down in 1973, and its research team dispersed to other pharmaceutical firms.
- Therapeutic areas
- OtherPulmonologyNeurology
- Modalities
- Small molecule
- Industry
- Pharma
02
Partnerships
Astra AB
Beyond the preview
Go deeper on Bofors Nobel-Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bofors Nobel-Pharma.